Epidemiological Analysis and Geographical Distribution of Patients Suffering from Rheumatoid Arthritis, Eligible for First-Line Therapy/Monotherapy Treatment with Subcutaneous Formulation of Tocilizumab in the Republic of Macedonia.

Autor: Gucev F; University Clinic of Rheumatology, Skopje, Republic of Macedonia., Perchinkova-Mishevska S; University Clinic of Rheumatology, Skopje, Republic of Macedonia., Bozinovski G; University Clinic of Rheumatology, Skopje, Republic of Macedonia., Kafedjiska I; University Clinic of Rheumatology, Skopje, Republic of Macedonia., Antova D; University Clinic of Rheumatology, Skopje, Republic of Macedonia., Damjanovska-Krstic L; University Clinic of Rheumatology, Skopje, Republic of Macedonia., Osmani B; University Clinic of Rheumatology, Skopje, Republic of Macedonia., Hadjihamza F; Roche Macedonia DOOELSkopje, Republic of Macedonia., Nikolov O; Roche Macedonia DOOELSkopje, Republic of Macedonia.

Publikováno v: Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) [Pril (Makedon Akad Nauk Umet Odd Med Nauki)] 2018 Dec 01; Vol. 39 (2-3), pp. 69-78.